Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 17 of 17 for “"Tau-PET"”.
-
Investigating the Use of [18-F] tau-PET Imaging as a Biomarker of tau Pathology in Retired Athletes at Risk of Neurodegeneration
… is characterized by abnormal accumulation of tau protein in the brains of affected athletes in a pattern distinct from other neurodegenerative diseases. There is currently no in vivo biomarker of tau pathology of chronic traumatic encephalopathy, and the diagnosis is made post-mortem. [18-F] …
-
Messung von Tau Proteinablagerungen mittels PET bei primären Tauopathien
Biomarker für die Tau Pathologie bei Patienten mit Progressiver Supranukleärer Blickparese (PSP) werden als diagnostisches Einschlusskriterium für Therapiestudien und zum Monitoring von krankheitsverändernden Effekten dringend benötigt. Aktuell existieren jedoch keine zugelassenen Methoden um die …
-
Novel Methods for Image Analysis to Evaluate Relationships Between Biomarkers in Alzheimer's Disease
… biomarkers, including pathological amyloid and tau measured with positron emission tomography (PET) and neurodegeneration measured with magnetic res-onance (MR), are part of the research framework for Alzheimer’s disease (AD). Abnormal brain amyloid is currently the earliest established …
-
To ascertain scientific reliability in PET imaging for Alzheimer disease
… to track abnormal levels of amyloid-β and tau, the pathological hallmarks of Alzheimer disease. Among these, positron emission tomography (PET) has emerged as an established standard that other biomarkers are compared to. However, as PET imaging moves from being used in research settings to …
-
De-Risking PET Radioligand Discovery for Neurodegenerative Diseases
… effectiveness for positron emission tomography (PET) imaging of neurodegeneration. Three proteins were targeted: 1) colony stimulating factor-1 receptor (CSF-1R); 2) glycogen synthase kinase-3 (GSK-3); and 3) transactivation response DNA-binding protein with molecular weight of 43 kDa (TDP-43). …
-
Sex-Differences in Early-Onset Alzheimer's Disease
… maps of gray matter density, amyloid, and tau PET burden. Chapter 3 analyses evaluated the impact of sex and APOE ε4 on plasma and cerebrospinal fluid (CSF) AD biomarkers. We included 201 EOAD, 64 EOnonAD, and 86 CN participants with plasma data; of these, 100 EOAD, 35 EOnonAD, and 38 CN …
-
Toward Reliable and Interpretable AI for 3D Medical Image Computing: Registration, Cross Modal Synthesis, and Resource Efficient Segmentation
… Structural MRI is widely available, whereas PET and MRE yield valuable molecular and mechanical biomarkers that are harder to obtain and scale. Learning-based models can fuse these complementary data to extract richer information, but struggle when anatomy is highly altered, behavior is hard …
-
Autoradiographic evaluation of amyloid-beta and tau radioligands in human brain tissue
… accumulation of abnormally phosphorylated tau protein. These proteinopathies are followed by the loss of synapses and neurons (neurodegeneration). Until 2023, AD could only be definitively diagnosed postmortem, at autopsy. However, in 2024, the Alzheimer’s Association published new criteria …
-
Bayesian Framework for Classification to Investigate Tau, Cortical Thickness, and Large-Scale Brain Networks Across the Alzheimer’s Disease Spectrum
… loss due to the accumulation and spread of tau proteins across the brain. Neuroimaging modalities such as T1-weighted magnetic resonance imaging (MRI) and tau positron emission tomography (PET) can quantify these disease processes. Though tau neurofibrillary tangles (NFTs) follow a …
-
Einsatz der Positronen-Emissions-Tomographie mit [18F]FDG für die Diagnostik von neurodegenerativen Erkrankungen aus dem frontotemporalen Formenkreis
FDG-PET als Maß für neuronale Schädigung wird bei verschiedenen neurodegenerativen Erkrankungen aus dem frontotemporalen Formenkreis diagnostisch eingesetzt. In der weiterführenden Diagnostik kommen darüber hinaus spezifische Radiotracer zum Einsatz. Hierbei befindet sich die Tau-PET aktuell in …
-
Imaging Genetics and Biomarker Variations of Clinically Diagnosed Alzheimer's Disease
… framework, defined in a 2018 as the A(amyloid)/T(tau)/N(neurodegeneration) framework after three of the hallmarks of Alzheimer’s disease. I first used imaging measures of amyloid, tau and neurodegeneration to study clinically diagnosed Alzheimer’s disease. After dividing subjects into early (onset …
-
Exploring modulators of tau spreading in Alzheimer’s disease through multi-modal neuroimaging biomarkers
… plaques decades before the eventual spreading of tau pathology which drives the development of dementia symptoms. There is significant heterogeneity within AD, leading to variations in how the condition manifests clinically and the trajectory in which it progresses. This clinical heterogeneity can …
-
Evaluating PET Imaging Biomarkers in Chronic Traumatic Encephalopathy
… their utility for positron emission tomography (PET) imaging of chronic traumatic encephalopathy (CTE). Two pathological mechanisms were targeted: 1) neuroinflammation and 2) tau protein aggregates. Neuroinflammatory PET biomarkers were evaluated in Chapter 2 in CTE post-mortem tissues compared …
-
Understanding emerging biomarkers and lifestyle factors in aging and Alzheimer disease
… diseases including in vivo assessments of tau burden and brain metabolism via positron emission tomography (PET) imaging and neurofilament light chain (NfL), a marker of neurodegeneration, via Age-related cognitive decline and pathological brain changes are a widespread and growing public …
-
Diffusion imaging markers of cerebral small vessel disease
… analyses between AD biomarkers (amyloid-beta, tau), conventional MRI markers of SVD, and global diffusion measures. Furthermore, we investigated regional associations between tau on positron emission tomography (PET) and diffusion measures in voxel-wise analyses. Our main findings are that …
-
Novel Imaging Biomarker for Neuroinflammation in Alzheimer's Disease
… senile plaques made of amyloid-beta (Aβ), tau tangles formed by hyperphosphorylated tau, neurodegeneration and neuroinflammation (38,43). A central fea-ture of AD pathophysiology is neurodegeneration, which results from the death of neurons associated with inflammatory processes involving …
-
The medial temporal lobe in aging and Alzheimer’s disease: A deep dive into anatomy, methodology, and clinical characterization
… and the accumulation of amyloid-beta (Aβ) and tau neurofibrillary tangle (NFT) pathology. The medial temporal lobe (MTL) is one of the earliest sites of NFT pathology, crucial for memory functioning, and is made up of cytoarchitectonic and functionally different subregions. These subregions are …